
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17426829
[patent_doc_number] => 20220054537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => MAGNESIUM-L-THREONATE AND NEUROTRANSMITTER COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/194733
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/194733 | MAGNESIUM-L-THREONATE AND NEUROTRANSMITTER COMPOSITIONS AND RELATED METHODS | Mar 7, 2021 | Pending |
Array
(
[id] => 18296015
[patent_doc_number] => 20230105701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => DISSOLUTION-ENHANCED OLAPARIB COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/908990
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908990 | DISSOLUTION-ENHANCED OLAPARIB COMPOSITION | Mar 3, 2021 | Abandoned |
Array
(
[id] => 17080571
[patent_doc_number] => 20210275577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR REGULATING INTRACELLULAR SIGNAL TRANSDUCTION
[patent_app_type] => utility
[patent_app_number] => 17/191417
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/191417 | MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR REGULATING INTRACELLULAR SIGNAL TRANSDUCTION | Mar 2, 2021 | Abandoned |
Array
(
[id] => 18214675
[patent_doc_number] => 11589581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Disinfectant formulation
[patent_app_type] => utility
[patent_app_number] => 17/184864
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8586
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184864 | Disinfectant formulation | Feb 24, 2021 | Issued |
Array
(
[id] => 16883843
[patent_doc_number] => 20210170038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => Biocampatible and Biodegradable Anionic Hydrogel System
[patent_app_type] => utility
[patent_app_number] => 17/183083
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/183083 | Biocampatible and Biodegradable Anionic Hydrogel System | Feb 22, 2021 | Abandoned |
Array
(
[id] => 16898978
[patent_doc_number] => 20210177894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Bis-Choline Tetrathiomolybdate for Treating Wilson Disease
[patent_app_type] => utility
[patent_app_number] => 17/182227
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182227
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182227 | Bis-Choline Tetrathiomolybdate for Treating Wilson Disease | Feb 21, 2021 | Abandoned |
Array
(
[id] => 17034932
[patent_doc_number] => 20210251890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => HEMOSTATIC COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/177894
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/177894 | Hemostatic compositions and related methods | Feb 16, 2021 | Issued |
Array
(
[id] => 19225522
[patent_doc_number] => 12005152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Microgel composition comprising collagen and method of preparing the same
[patent_app_type] => utility
[patent_app_number] => 17/168780
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 4687
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17168780
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/168780 | Microgel composition comprising collagen and method of preparing the same | Feb 4, 2021 | Issued |
Array
(
[id] => 16870069
[patent_doc_number] => 20210163536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN
[patent_app_type] => utility
[patent_app_number] => 17/166756
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166756
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/166756 | MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN | Feb 2, 2021 | Abandoned |
Array
(
[id] => 19674594
[patent_doc_number] => 12186432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Preparation method of sustained-release microparticles
[patent_app_type] => utility
[patent_app_number] => 17/165690
[patent_app_country] => US
[patent_app_date] => 2021-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17325
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17165690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/165690 | Preparation method of sustained-release microparticles | Feb 1, 2021 | Issued |
Array
(
[id] => 18239853
[patent_doc_number] => 20230072164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => GRANULAR PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION FROM A PRE-FILLED STRAW AND METHOD OF MANUFACTURING SUCH PHARMACEUTICAL PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/759688
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759688 | GRANULAR PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION FROM A PRE-FILLED STRAW AND METHOD OF MANUFACTURING SUCH PHARMACEUTICAL PRODUCT | Jan 27, 2021 | Pending |
Array
(
[id] => 17168632
[patent_doc_number] => 20210322302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/156781
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/156781 | Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue | Jan 24, 2021 | Issued |
Array
(
[id] => 16868588
[patent_doc_number] => 20210162055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/147200
[patent_app_country] => US
[patent_app_date] => 2021-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147200 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES | Jan 11, 2021 | Abandoned |
Array
(
[id] => 20817687
[patent_doc_number] => 12673141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-07
[patent_title] => System for shape memory alloy enabled drug release
[patent_app_type] => utility
[patent_app_number] => 18/013918
[patent_app_country] => US
[patent_app_date] => 2020-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 0
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013918
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013918 | System for shape memory alloy enabled drug release | Dec 30, 2020 | Issued |
Array
(
[id] => 16822824
[patent_doc_number] => 20210138117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR
[patent_app_type] => utility
[patent_app_number] => 17/136830
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136830 | Compounds and matrices for use in bone growth and repair | Dec 28, 2020 | Issued |
Array
(
[id] => 17503615
[patent_doc_number] => 20220096717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => AXITINIB-LOADED NANOFIBER MEMBRANE, PREPARATION METHOD FOR THE SAME, AND ITS USE OF ANTI-ADHESION AFTER A SURGERY
[patent_app_type] => utility
[patent_app_number] => 17/136630
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136630 | AXITINIB-LOADED NANOFIBER MEMBRANE, PREPARATION METHOD FOR THE SAME, AND ITS USE OF ANTI-ADHESION AFTER A SURGERY | Dec 28, 2020 | Abandoned |
Array
(
[id] => 19256939
[patent_doc_number] => 12016968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Highly efficacious hemostatic adhesive polymer scaffold
[patent_app_type] => utility
[patent_app_number] => 17/133089
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7474
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/133089 | Highly efficacious hemostatic adhesive polymer scaffold | Dec 22, 2020 | Issued |
Array
(
[id] => 16776367
[patent_doc_number] => 20210113444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => CONDITIONING SHAMPOO COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/247602
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17247602
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/247602 | Conditioning shampoo composition | Dec 16, 2020 | Issued |
Array
(
[id] => 18737974
[patent_doc_number] => 20230346876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => IMPROVED WOUND CARE DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/782893
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/782893 | IMPROVED WOUND CARE DEVICE | Dec 15, 2020 | Pending |
Array
(
[id] => 18244375
[patent_doc_number] => 20230076686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => LOW ODOR HIGH LEVEL DISINFECTANT
[patent_app_type] => utility
[patent_app_number] => 17/790877
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790877 | LOW ODOR HIGH LEVEL DISINFECTANT | Dec 15, 2020 | Pending |